Solanezumab, Gantenerumab Fail to Slow Cognitive Decline in Inherited Alzheimer Disease Trial
February 10th 2020Additional analysis of secondary endpoints and biomarkers are expected to be presented at the Advances in Alzheimer’s and Parkinson’s Therapies (AAT-AD/PD) Focus Meeting in April 2020.
Study Reveals New Combination of Biomarkers Useful for Predicting MS
February 10th 2020The antioxidants adiponectin, total radical-trapping antioxidant parameter, sulfhydryl groups, zinc, and soluble tumor necrosis factor receptor 2 all play a role in the pathophysiology of multiple sclerosis.
Undiagnosed OSA Linked to High Health Care Costs and Utilization
February 6th 2020New Medicare data has suggested that those with undiagnosed obstructive sleep apnea have higher annual health care costs than their counterparts, with this high economic burden accompanying already impacted function and quality of life.